Cancer Family
Esophageal Neoplasm
CI-CAN-00000174Explore in graph →
Non-malignant555 active trials6 approved drugs12 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000174Explore in graph →
Clinical trials
2,208 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02320734 | Deep Neuromuscular Relaxation in Patients for Thoraco-laparoscopic Esophagectomy(DEPTH) | completed | Phase 4 | 66 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Sep 19, 2016 | clinicaltrials |
| NCT01608022 | A Phase II Trial of PF-00299804 in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus | completed | Phase 2 | 48 | Yonsei UniversityOTHER | 1 | Sep 7, 2016 |
| clinicaltrials |
| NCT02879227 | Radiochemotherapy in Elderly Patients With Oesophagus Cancer(Chronos) | completed | Phase 2 | 23 | Centre Hospitalier Universitaire de BesanconOTHER | 0 | Aug 25, 2016 | clinicaltrials |
| NCT00176800 | Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma | completed | Phase 2 | 69 | University of Michigan Rogel Cancer CenterOTHER | 1 | Aug 22, 2016 | clinicaltrials |
| NCT01551433 | Tissue Oxygenation Are Associated With Anastomotic Leak Rates After an Ivor Lewis Esophagectomy | completed | — | 166 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 18, 2016 | clinicaltrials |
| NCT00588640 | Study of D-Methadone in Patients With Chronic Pain | completed | Phase 1 / Phase 2 | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT02861690 | Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal Carcinoma | completed | Phase 2 | 72 | Sun Yat-sen UniversityOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT00003137 | Irinotecan in Treating Patients With Advanced Cancer of the Stomach | completed | Phase 2 | 70 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 14, 2016 | clinicaltrials |
| NCT00004235 | Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach | completed | Phase 2 | 47 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 14, 2016 | clinicaltrials |
| NCT02324881 | Pain Management Smartphone Application for Patients With Stage III-IV Head and Neck Cancer Undergoing Radiation Therapy | completed | N/A | 24 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT01325883 | The Effect of Chemotherapy and Surgery for Cancer on Exercise Capacity | completed | — | 253 | Liverpool University Hospitals NHS Foundation TrustOTHER_GOV | 1 | Jul 12, 2016 | clinicaltrials |
| NCT00003118 | Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | completed | Phase 3 | 56 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 4, 2016 | clinicaltrials |
| NCT01129206 | Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy | completed | Phase 2 | 6 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jun 1, 2016 | clinicaltrials |
| NCT00544362 | Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery | completed | Phase 1 / Phase 2 | 33 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | May 30, 2016 | clinicaltrials |
| NCT00354679 | Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer | completed | Phase 2 | 34 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 16, 2016 | clinicaltrials |
| NCT00319735 | Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas | completed | Phase 2 | 41 | Nasser Hanna, M.D.OTHER | 1 | Apr 28, 2016 | clinicaltrials |
| NCT00701857 | Pemetrexed, Cisplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer | completed | Phase 1 | 10 | University of ArizonaOTHER | 1 | Apr 20, 2016 | clinicaltrials |
| NCT00524121 | Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer | completed | Phase 2 | 22 | Roswell Park Cancer InstituteOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT00593723 | IMRT Tomotherapy for Esophagus Cancer(IMRT) | completed | Phase 1 | 26 | Washington University School of MedicineOTHER | 1 | Apr 5, 2016 | clinicaltrials |
| NCT00365508 | Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking | completed | Phase 4 | 642 | Fox Chase Cancer CenterOTHER | 1 | Mar 29, 2016 | clinicaltrials |
| NCT02030769 | Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer | completed | N/A | 1,000 | Xijing Hospital of Digestive DiseasesOTHER | 1 | Mar 29, 2016 | clinicaltrials |
| NCT01836913 | Value of PET-CT in Radiation Treatment Planning for Patients With Esophageal Cancer(RESPECT) | completed | — | 90 | University Medical Center GroningenOTHER | 1 | Mar 23, 2016 | clinicaltrials |
| NCT00390416 | Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma | completed | Phase 2 | 48 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 14, 2016 | clinicaltrials |
| NCT00757172 | Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction | completed | Phase 2 | 70 | Alliance for Clinical Trials in OncologyOTHER | 1 | Mar 11, 2016 | clinicaltrials |
| NCT01733719 | Barrett&Apos;s Intervention for Dysplasia by Endoscopy(BRIDE) | completed | N/A | 76 | University Hospitals, LeicesterOTHER | 1 | Mar 11, 2016 | clinicaltrials |
| NCT02385604 | The Predictive Value of CT-PET in Esophageal Cancer | completed | — | 250 | St. James's Hospital, IrelandOTHER | 1 | Mar 10, 2016 | clinicaltrials |
| NCT01980394 | Esophageal Stump Washout | completed | N/A | 50 | Kantonsspital LiestalOTHER | 1 | Feb 25, 2016 | clinicaltrials |
| NCT01854749 | S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical Study | completed | Phase 2 | 57 | Fudan UniversityOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT02607982 | CCRT for Esophageal Cancer. | completed | Phase 2 | 34 | Hangzhou Cancer HospitalOTHER | 0 | Feb 17, 2016 | clinicaltrials |
| NCT00737438 | Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma | completed | Phase 2 | 22 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 3, 2016 | clinicaltrials |
| NCT00747448 | CryoSpray Ablation (TM) GI Patient Registry | completed | — | 199 | CSA Medical, Inc.INDUSTRY | 1 | Feb 2, 2016 | clinicaltrials |
| NCT00590031 | Phase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan. | completed | Phase 2 | 61 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 25, 2016 | clinicaltrials |
| NCT00515216 | Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors | completed | Phase 2 | 26 | Vanderbilt UniversityOTHER | 1 | Jan 7, 2016 | clinicaltrials |
| NCT00586989 | Endoscopic Tri-Modal Imaging in Patients With Barrett's Esophagus(ETMI) | completed | — | 60 | Mayo ClinicOTHER | 2 | Jan 7, 2016 | clinicaltrials |
| NCT00268346 | Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction Cancer | completed | Phase 2 | 58 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 5, 2016 | clinicaltrials |
| NCT01469598 | Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer | completed | Phase 2 | 24 | Samsung Medical CenterOTHER | 1 | Dec 29, 2015 | clinicaltrials |
| NCT01474642 | Phase II Trial of XP Versus XG in Advanced Esophageal Squamous Cell Carcinoma | completed | Phase 2 | 64 | Samsung Medical CenterOTHER | 1 | Dec 29, 2015 | clinicaltrials |
| NCT00861094 | Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer | completed | Phase 2 / Phase 3 | 266 | UNICANCEROTHER | 1 | Dec 18, 2015 | clinicaltrials |
| NCT01172028 | Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 33 | University of ArizonaOTHER | 1 | Dec 3, 2015 | clinicaltrials |
| NCT02302118 | Esophagogastrectomy Versus Extended Gastrectomy in AEG II(AEG-II-EG) | completed | — | 128 | Universitätsklinikum Hamburg-EppendorfOTHER | 1 | Dec 3, 2015 | clinicaltrials |
| NCT00397904 | Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin | completed | Phase 2 | 16 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 25, 2015 | clinicaltrials |
| NCT00011960 | Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery | completed | Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 1 | Nov 17, 2015 | clinicaltrials |
| NCT01135849 | B-Receptor Signaling in Cardiomyopathy | completed | — | 99 | Daniel BernsteinOTHER | 1 | Nov 17, 2015 | clinicaltrials |
| NCT00754468 | Study of CryoSpray Ablation(TM)to Determine Treatment Effect, Depth of Injury, and Side Effects in the Esophagus.(ESODOI) | completed | Phase 4 | 7 | CSA Medical, Inc.INDUSTRY | 1 | Nov 4, 2015 | clinicaltrials |
| NCT01932580 | Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal Adenocarcinoma | completed | Phase 2 | 10 | McGill UniversityOTHER | 1 | Oct 27, 2015 | clinicaltrials |
| NCT01998230 | Early Oral Feeding Following Thoracolaparoscopic Oesophagectomy in Patients With Esophageal Cancer | completed | Phase 3 | 280 | Yin LiOTHER_GOV | 1 | Oct 16, 2015 | clinicaltrials |
| NCT00258323 | Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer | completed | Phase 2 | 80 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 30, 2015 | clinicaltrials |
| NCT00397384 | Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer | completed | Phase 1 | 43 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2015 | clinicaltrials |
| NCT01871636 | ESD Versus EMR for Treatment of Early Barrett's Adenocarcinoma | completed | N/A | 40 | Evangelisches Krankenhaus DüsseldorfOTHER | 1 | Sep 9, 2015 | clinicaltrials |
| NCT00578071 | Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer(POXX) | completed | Phase 1 / Phase 2 | 29 | Brian CzitoOTHER | 1 | Jul 2, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Sep 19, 2016source: clinicaltrials